The National Health Commission said on Nov 3 that 21 COVID-19 patients were discharged from hospitals after recovery on the Chinese mainland on Nov 2.
Three new locally transmitted COVID-19 cases were reported on the Chinese mainland on Nov 1, all in Northwest China's Xinjiang Uygur autonomous region, the National Health Commission said on Nov 2.
A COVID-19 vaccine candidate developed by the Institute of Microbiology under the Chinese Academy of Sciences has shown to be safe in early-stage trials, suggesting potential for further clinical tests.
The National Health Commission said on Oct 30 that 24 COVID-19 patients were discharged from hospitals after recovery on the Chinese mainland on Oct 29.
Chinese health authority said Oct 28 that it received reports of 42 new confirmed COVID-19 cases on the Chinese mainland Oct 27, including 22 that were domestically transmitted and 20 imported.
Northwest China's Xinjiang Uygur autonomous region has completed COVID-19 testing for all 4.75 million people in its southern prefecture of Kashgar following the recent new local cases, local officials said on Oct 27.
No new locally-transmitted COVID-19 cases were reported on Oct 25 across the Chinese mainland, the National Health Commission said on Oct 26.
China's National Health Commission on Oct 25 sent a working group to Northwest China's Xinjiang Uygur autonomous region to oversee COVID-19 epidemic-control work.
A total of 60,000 volunteers have received Chinese COVID-19 vaccines during phase-3 clinical trials, and no severe side effects have been reported, a Chinese official said on Oct 20.
China's total annual production capacity of COVID-19 vaccines will likely reach 610 million doses by the end of the year, a Chinese official said on Oct 20.
No new locally transmitted COVID-19 cases were reported on Oct 18 across the Chinese mainland, the National Health Commission said on Oct 19.
The National Health Commission said on Oct 19 that 16 COVID-19 patients were discharged from hospitals after recovery on the Chinese mainland on Oct 18.
Over 8.82 million people have been sampled for nucleic acid testing, as of 6 pm on Oct 14, in East China's Qingdao city, after it began a citywide COVID-19 testing campaign on Oct 12.
Chinese health authority said on Oct 13 that it received reports of 13 new confirmed COVID-19 cases on the Chinese mainland on Oct 12, including six that were domestically transmitted.
The Chinese mainland reported 12 new imported COVID-19 cases on Sept 28, bringing the total number of imported cases to 2,835, the National Health Commission said on Sept 29.
China's nucleic acid testing capacity has hugely improved, which is the key to the epidemic response in the coming autumn-winter season, a health official said Sept 25.
No new locally transmitted COVID-19 cases were reported on Sept 20 across the Chinese mainland, the National Health Commission said on Sept 21.
China's National Health Commission on Sept 15 released the latest (seventh) version of COVID-19 prevention and control guidelines, making revisions contents such as COVID-19 etiological and epidemiological features, as well as epidemic monitoring and handling.
No new locally-transmitted COVID-19 cases were reported on Sept 13 across the Chinese mainland, the National Health Commission said on Sept 14.
The National Health Commission said on Sept 10 that 11 COVID-19 patients were discharged from hospitals after recovery on the Chinese mainland on Sept 9.